MatsOlofSandenMDMBA

Pathology • Bensalem, PA

Anatomic Pathology, Clinical Pathology

Chief Medical Officer

Join to view full profile

Dr. Sanden is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sanden's full profile

Already have an account?

Office
3494 Progress Dr
Bensalem, PA 19020
Phone+1 302-438-7239

Summary

Dr. Mats Sanden is Chief Medical Officer for a clinical Laboratory in Bensalem, PA. He received his medical degree from University of Gothenburg Faculty of Medicine and has been in practice 29 years. He also speaks multiple languages, including Swedish. He specializes in molecular pathology, molecular oncology diagnostics, anatomic pathology, and clinical pathology.

Education & Training

George Washington UmniversityMBA, Business Administration, 2011 - 2013
Washington Hospital CenterResidency, Pathology-Anatomic and Clinical, 1993 - 1997
Univ of Gothenburg- Fac MedClass of 1988

Certifications & Licensure

NY State Medical License 2011 - 2024
PA State Medical License 1996 - 2024
TX State Medical License 2019 - 2024
FL State Medical License 2018 - 2023
NC State Medical License 2022 - 2023
NJ State Medical License 1998 - 2023
NV State Medical License 2023 - 2023
MD State Medical License 2000 - 2021
DE State Medical License 2000 - 2015
CT State Medical License 2010 - 2012
American Board of Pathology Anatomic Pathology & Clinical Pathology
Join now to see all

Publications & Presentations

PubMed

82 citations
Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears
Gila Lithwick-Yanai, Nir Dromi, Alexander Shtabsky, Sara Morgenstern, Yulia Strenov
Journal of Clinical Pathology. 2017-06-01

Journal Articles

Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilizing fine needle aspirate smears
Gila Lithwick-Yanai, Nir Dromi, Alexander Shtabsky , Sara Morgenstern, Yulia Strenov , Meora Feinmesser Vladimir Kravtsov , Marino E Leon, Marián Hajdúch, Syed Z Ali, ..., J Clin Pathology, 10/26/2016
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown p...
Pentheroudakis G, Pavlidis N, Fountzilas G, Krikelis D, Goussia A, Stoyianni A, Sanden M, St Cyr B, Yerushalmi N, Benjamin H, Meiri E, Chajut A, Rosenwald S, Aharonov ..., Mol Cancer, 6/10/2013
Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinoma
Yael Spector, Eddie Fridman, Shai Rosenwald, Sofia Zilber,Yajue Huang, Iris Barshack, Orit Zion, Heather Mitchell, Mats Sanden, Eti Meiri, Mol Oncol, 3/26/2013
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of mat...
Pentheroudakis G, Spector Y, Krikelis D, Kotoula V, Meiri E, Malamou-Mitsi V, Fountzilas G, Sanden M, Pavlidis N, Benjamin H, Aharonov R, Clin Exp Metastasis, 11/4/2012
Classification of the four main types of lung cancer using a microRNA-based diagnostic assay
Gilad S, Lithwick-Yanai G, Barshack I, Benjamin S, Krivitsky I, Edmonston TB, Bibbo M, Thurm C, Horowitz L, Huang Y, Feinmesser M, Hou JS, St Cyr B, Burnstein I, Gibor..., J Mol Diagn, 6/27/2012
Join now to see all

Professional Memberships

Other Languages

Swedish